ReviewJournal of cancer research and clinical oncology2023

Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients.

Ryoko Inaba Higashiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.